Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.25 USD | +5.98% | -0.93% | -38.18% |
04-16 | SAB Biotherapeutics, Inc. Provides SAB-142 Trial Update | CI |
04-02 | HC Wainwright Adjusts Price Target on SAB Biotherapeutics to $6 From $10, Maintains Buy Rating | MT |
- Stock Market
- Equities
- SABS Stock
- News SAB Biotherapeutics, Inc.